Status:

COMPLETED

SARS-COV2 Pandemic Serosurvey and Blood Sampling

Lead Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Conditions:

SARS-COV2 Virus

Eligibility:

All Genders

18+ years

Brief Summary

Background: Respiratory virus outbreaks and pandemics, such as SARS, MERS, and the new SARS-COV2 virus, have major impacts worldwide. Researchers must act quickly to learn about the exposures and imm...

Detailed Description

It has been demonstrated that respiratory virus outbreaks and pandemics, such as influenza, SARS, MERS, and now the newly emerged SARS-COV2 virus, have a major impact on morbidity and mortality worldw...

Eligibility Criteria

Inclusion

  • INCLUSION CRITERIA:
  • \>= 18 years of age.
  • Willing and able to complete a verbal telephone consent.
  • Willing to undergo one blood draw or home blood sampling.
  • Willing to have blood samples stored for future research.
  • Have previously participated in Phase 1 of this study (inclusion for Phase II only)
  • Co-enrollment Guidelines
  • Participants may be co-enrolled in other research studies.
  • EXCLUSION CRITERIA:
  • Confirmed history of COVID19 infection or exposure (exclusion for Phase I only)
  • Current symptoms consistent with COVID19 infection
  • Any condition or event that, in the PI s opinion, may substantially increase the risk associated with study participation or compromise the study's scientific objectives. Conditions that exclude a subject are considered to be unlikely, but an example would include having a blood clotting disorder that would make it unsafe to obtain blood samples.
  • Not willing to have blood samples stored for future research.

Exclusion

    Key Trial Info

    Start Date :

    August 26 2020

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    January 21 2022

    Estimated Enrollment :

    11363 Patients enrolled

    Trial Details

    Trial ID

    NCT04334954

    Start Date

    August 26 2020

    End Date

    January 21 2022

    Last Update

    January 26 2024

    Active Locations (3)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (3 locations)

    1

    University of Alabama

    Birmingham, Alabama, United States, 35233

    2

    National Institutes of Health Clinical Center

    Bethesda, Maryland, United States, 20892

    3

    University of Pittsburgh

    Pittsburgh, Pennsylvania, United States, 15261